US FDA’s Foreign Data Policy Faces Its Greatest Test From Chinese PD-1/L1 Inhibitors

 
• By Bridget Silverman
  
Connected network around planet Earth from space for global communication technology concept in Asia as Internet of Things, mobile web, fintech blockc - Image ID: 2ARNH7W (Alamy)
How much of an impact will the country where data originated have on US FDA reviews? • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approval Standards

More from Pathways & Standards